Efektywnosc szczepionki Streptovac w zwalczaniu streptokokozy swin

• Autorzy: Pejsak Z , Wojciechowski J. , Porowski M. , Walachowski M. , Zmudzki J.

Warianty tytułu

EN

Efficacy of Streptovac vaccine for controlling streptococcosis

• Języki publikacji: PL

Abstrakty

EN

The aim of the study was to estimate the efficacy of Streptovac vaccine in controlling Streptococcus suis infections in field conditions in swine, Streptovac vaccine contains no less than 8.5 × 108 inactivated cells of S. suis type 2 and a similar number of S. suis type 1/2. The vaccine includes two adjuvants: aluminum hydroxide and mineral oil (Emulsigen). The experiment was performed on 3 farms: S, H and P with total of 4,400 sows (3,000, 1,100 and 300 sows). Clinical symptoms of streptococcosis occurred mainly among weaners between 7-8 weeks of age. Clinical signs associated with changes in the central nervous system were mainly observed. Losses due to streptococcosis in farms varied from 4-6%. Streptovac was used to immunize pigs from 3 different experimental groups in each farm. In farm S - 1,462 farm P - 447 and farm H - 1,307 animals were vaccinated. Vaccination was performed just before weaning and 3 weeks later; 2 ml of vaccine was applied i.m. One group of pigs in each farm served as the control. The parameters of production in every experimental group were compared with the results in the control group in order to evaluate the efficacy of the vaccine. The following criteria were evaluated: percentage of weaners with clinical signs of infection, percentage of pigs which died from streptococci with body weight on the day of weaning and moving from weaning house to fattening house, mean body weight gains during the 2 month period of observation. The analyzed results indicated a significant reduction in all farms in the average number of pigs with typical signs of infection in the central nervous system: in farm S - 4.58% in the experimental group and 7.92% in the control one; in farm P - 6.04% and 9.33% and in farm H - 3.74% and 6.56%. A similarly significantly lower mortality rate in was observed in the vaccinated pigs. The average death rate for control groups in farm S - was 4.87% and for experimental groups 1.64%; in farm P - 6.00% and 3.13% and in farm H - 4.17% and 2.06%. The differences between body weight gains among vaccinated and control pigs were not significant. To summarize, Streptovac vaccine used in farms where streptococcosis is caused by field strains cross-reacting with vaccine strains ensures a significant reduction of losses caused by S. suis.

Słowa kluczowe

PL

streptokokoza; trzoda chlewna; skutecznosc; szczepionka Streptovac; zwalczanie chorob zwierzat; choroby zwierzat

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2008
• Tom: 64
• Numer: 01
• Opis fizyczny: s.113-116,tab.,bibliogr.

Twórcy

autor

Pejsak Z

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Wojciechowski J.

autor

Porowski M.

autor

Walachowski M.

autor

Zmudzki J.

Bibliografia

• 1. Chatellier S., Harel J., Zhang Y., Gottschalk M., Higgins R., Devriese L., Brousseau R.: Phylogenetic diversity of Streptococcus suis strains of various serotypes as revealed by 16S rRNA gene sequence comparison. Int. J. Syst. Bacteriol. 1998, 48, 581-589.
• 2. Del Campo Sepulveda E. M., Altman E., Kobisch M., D'Allaire S., Gottschalk M.: Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA. Vet. Microbiol. 1996, 52, 113-125.
• 3. Gottschalk M., Higgins R., Boudreau M.: Use of polyvalent coagglutination reagents for serotyping of Streptococcus suis. J. Clin. Microbiol. 1993, 31, 2192-2194.
• 4. Holt M. E., Enright M. R., Alexander T. J.: Immunization of pigs with killed cultures of Streptococcus suis type 2. Res. Vet. Sci. 1990, 48, 23-27.
• 5. Holt M. E., Enright M. R., Alexander T. J.: Immunization of pigs with live cultures of Streptococcus suis type 2. Res. Vet. Sci. 1988, 45, 349-352.
• 6. Jacobs A. A. C., Van Den Berg J. G., Loeffen P. L. W.: Protection of experimentally infected pigs by suilysin, the tiol-activated haemolysin of Streptococcus suis. Vet. Rec. 1996, 139, 225-228.
• 7. Kilpper-Balz R., Schleifer K. H.: Streptococcus suis sp. nov., nom. rev. Int. J. Sys. Bacteriol. 1987, 37, 160-162.
• 8. Pejsak Z., Tarasiuk K., Sadoch L.: Nagłe zachorowania i padnięcia warchlaków i tuczników zakażonych Streptococcus suis typ II. Medycyna Wet. 1989, 45, 525-528.
• 9. Pejsak Z., Żmudzki J., Bogusz R.: Przydatność immunoprofilaktyki w ograniczaniu strat świń na tle zakażeń Streptococcus suis typ 2. Medycyna Wet. 2001, 57, 251-254.
• 10. Szczotka A.: Ocena właściwości feno- i genotypowych krajowych izolatów Streptococcus suis. Praca doktorska, PIWet-PIB 2007.
• 11. Truszczyński M., Pejsak Z.: Bierna i czynna odporność przeciw chorobom zakaźnym u oseska do okresu poodsadzeniowego. Medycyna Wet. - w druku.
• 12. Wisselink H. J., Vecht U., Stockhofe-Zurwieden N., Smith H. E.: Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet. Rec. 2001, 148, 473-477.